Effects of mutations and glycosylations on STS activity: A site-directed mutagenesis study

Molecular and Cellular Endocrinology

Volumn 283, Issue 1-2, 2008, Pages 76-82

  Stengel, Chloe ^a   Newman, Simon P ^a   Day, Joanna M ^a   Tutill, Helena J ^a   Reed, Michael J ^a   Purohit, Atul ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Breast cancer; Glycosylation; MCF 7 cells; Mutagenesis; Steroid sulphatase; STS antibody

Indexed keywords

ASPARAGINE; HISTIDINE; STERYL SULFATASE;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME STRUCTURE; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREACTIVITY; MOUSE; MUTAGENESIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GLYCOSYLATION; HUMANS; IMMUNE SERA; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; POINT MUTATION; STERYL-SULFATASE;

EID: 39149122462     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.11.012     Document Type: Article

References (30)

1. Alperin E.S., and Shapiro L.J. Characterization of point mutations in patients with X-linked ichthyosis. Effects on the structure and function of the steroid sulfatase protein. J. Biol. Chem. 272 (1997) 20756-20763
2. Basler E., Grompe M., Parenti G., Yates J., and Ballabio A. Identification of point mutations in the steroid sulfatase gene of three patients with X-linked ichthyosis. Am. J. Hum. Genet. 50 (1992) 483-491
3. Billich A., Nussbaumer P., and Lehr P. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J. Steroid. Biochem. Mol. Biol. 73 (2000) 225-235
4. Conary J., Nauerth A., Burns G., Hasilik A., and von Figura K. Steroid sulfatase. Biosynthesis and processing in normal and mutant fibroblasts. Eur. J. Biochem. 158 (1986) 71-76
5. Elger W., Schwarz S., Hedden A., Reddersen G., and Schneider B. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J. Steroid. Biochem. Mol. Biol. 55 (1995) 395-403
6. Engvall E., and Perlman P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry 8 (1971) 871-874
7. Gonzalez-Huerta L.M., Riviera-Vega M.R., Kofman-Alfeuro S.H., and Cuevas-Covarrubias S.A. Novel missense mutation (Arg432Cys) in a patient with steroid sulphatase-deficiency. Clin. Endocrinol. (Oxf.) 59 (2003) 263-264
8. Heijne G.V. The distribution of positively charged residues in bacterial inner membrane proteins correlates with the trans-membrane topology. EMBO J. 5 (1986) 3021-3027
9. Hernandez-Guzman F.G., Higashiyama T., Pangborn W., Osawa Y., and Ghosh D. Structure of human estrone sulfatase suggests functional roles of membrane association. J. Biol. Chem. 278 (2003) 22989-22997
10. Hsu L.C., Hu M.C., Cheng H.C., Lu J.C., and Chung B.C. The N-terminal hydrophobic domain of P450c21 is required for membrane insertion and enzyme stability. J. Biol. Chem. 268 (1993) 14682-14686
11. Hurtley S.M., and Helenius A. Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5 (1989) 277-307
12. Miyoshi Y., Ando A., Hasegawa S., Ishitobi M., Taguchi T., Tamaki Y., and Noguchi S. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin. Cancer Res. 9 (2003) 2288-2293
13. Pakula A.A., and Sauer R.T. Genetic analysis of protein stability and function. Annu. Rev. Genet. 23 (1989) 289-310
14. Pasqualini J.R., Ebert C., and Chetrite G.S. Biological effects of progestins in breast cancer. Gynecol. Endocrinol. 15 Suppl. 6 (2001) 44-52
15. Purohit A., Hejaz H.A., Woo L.W., van Strien A.E., Potter B.V., and Reed M.J. Recent advances in the development of steroid sulphatase inhibitors. J. Steroid. Biochem. Mol. Biol. 69 (1999) 227-238
16. Purohit A., Potter B.V., Parker M.G., and Reed M.J. Steroid sulphatase: expression, isolation and inhibition for active-site identification studies. Chem. Biol. Interact. 109 (1998) 183-193
17. Purohit A., Williams G.J., Howarth N.M., Potter B.V., and Reed M.J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 34 (1995) 11508-11514
18. Purohit A., Williams G.J., Roberts C.J., Potter B.V., and Reed M.J. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. Int. J. Cancer 63 (1995) 106-111
19. Reed M.J., Purohit A., Woo L.W., Newman S.P., and Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 26 (2005) 171-202
20. Shapiro L.J., Yen P., Pomerantz D., Martin E., Rolewic L., and Mohandas T. Molecular studies of deletions at the human steroid sulfatase locus. Proc. Natl. Acad. Sci. USA 86 (1989) 8477-8481
21. Stanway S.J., Purohit A., Woo L.W., Sufi S., Vigushin D., Ward R., Wilson R.H., Stanczyk F.Z., Dobbs N., Kulinskaya E., et al. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin. Cancer Res. 12 (2006) 1585-1592
22. Stein C., Hille A., Seidel J., Rijnbout S., Waheed A., Schmidt B., Geuze H., and von Figura K. Cloning and expression of human steroid-sulfatase. Membrane topology, glycosylation, and subcellular distribution in BHK-21 cells. J. Biol. Chem. 264 (1989) 13865-13872
23. Sugawara T., Nomura E., and Hoshi N. Both N-terminal and C-terminal regions of steroid sulfatase are important for enzyme activity. J. Endocrinol. 188 (2006) 365-374
24. Sugawara T., Shimizu H., Hoshi N., Fujimoto Y., Nakajima A., and Fujimoto S. PCR diagnosis of X-linked ichthyosis: identification of a novel mutation (E560P) of the steroid sulfatase gene. Hum. Mutat. 15 (2000) 296
25. Utsumi T., Yoshimura N., Maruta M., Takeuchi S., Ando J., Maeda K., and Harada N. Significance of steroid sulfatase expression in human breast cancer. Breast Cancer 6 (1999) 298-300
26. Valdes-Flores M., Jimenez Vaca A.L., Kofman-Alfaro S.H., and Cuevas-Covarrubias S.A. Characterization of a novel point mutation (Arg432His) in X-linked ichthyosis. Acta Derm. Venereol. 81 (2001) 54-55
27. von Figura K., Schmidt B., Selmer T., and Dierks T. A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease. Bioessays 20 (1998) 505-510
28. Warren J.C., and French A.P. Distribution of steroid sulfatase in human tissues. J. Clin. Endocrinol. Metab. 25 (1965) 278-282
29. Woo L.L., Purohit A., Malini B., Reed M.J., and Potter B.V. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Chem. Biol. 7 (2000) 773-791
30. Yen P.H., Allen E., Marsh B., Mohandas T., Wang N., Taggart R.T., and Shapiro L.J. Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange. Cell 49 (1987) 443-454